Enteric Hyperoxaluria News Today

Synlogic, Inc. (NASDAQ:SYBX – Get Rating) insider Aoife Brennan sold 8,894 shares of the stock in a transaction dated Monday, April 4th. The stock was sold at an average price of $2.45, for a total transaction of $21,790.30. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at […]

Synlogic, Inc. (NASDAQ:SYBX – Get Rating) has earned a consensus recommendation of “Buy” from the six brokerages that are covering the firm, MarketBeat.com reports. One analyst has rated the stock with a hold recommendation and five have given a buy recommendation to the company. The average twelve-month price target among analysts that have issued a […]

Synlogic (NASDAQ:SYBX – Get Rating)‘s stock had its “buy” rating reaffirmed by equities researchers at Oppenheimer in a research report issued on Friday, TipRanks reports. They presently have a $7.00 target price on the biotechnology company’s stock. Oppenheimer’s target price suggests a potential upside of 213.90% from the stock’s current price. A number of other […]

Synlogic (NASDAQ:SYBX – Get Rating) had its price objective cut by stock analysts at SVB Leerink from $11.00 to $8.00 in a report issued on Friday, Benzinga reports. The firm presently has an “outperform” rating on the biotechnology company’s stock. SVB Leerink’s target price points to a potential upside of 292.16% from the company’s previous […]

Zacks Investment Research cut shares of Synlogic (NASDAQ:SYBX – Get Rating) from a buy rating to a hold rating in a research report sent to investors on Tuesday, Zacks.com reports. According to Zacks, “Synlogic, Inc. engaged in the development of a novel class of living Synthetic Biotic(TM) medicines based on its proprietary drug discovery and […]

/PRNewswire/ -- The "Thermostable Vaccines and Thermostable Biologics Market by Type of Molecule, Target Indications, Type of Therapy, Key Players, and Key...

/PRNewswire/ -- The "Thermostable Vaccines and Thermostable Biologics Market by Type of Molecule, Target Indications, Type of Therapy, Key Players, and Key...

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

Allena Pharmaceuticals Provides Clinical and Corporate Update - Jan 04, 2022 - read this article along with other careers information, tips and advice on BioSpace

/PRNewswire/ -- Synlogic, Inc. (Nasdaq: SYBX), a clinical stage company bringing the transformative potential of synthetic biology to medicine, today announced...